A limited supply of tixagevimab and cilgavimab (Evusheld™) is available at Peninsula Health for use in high-risk people for pre-exposure prophylaxis for COVID-19 for eligible patients.
Tixagevimab and cilgavimab (Evusheld™) are monoclonal antibodies designed to block viral attachment and entry into cells. The Therapeutic Goods Administration (TGA) has provisionally approved the use of Evusheld™ for COVID-19 pre-exposure prophylaxis.
GP specialists and Non-GP specialists may refer to Peninsula Health in the following way using the link to prescribing resources:
- Evusheld™ prescribing resources for GPs and specialists | health.vic.gov.au
- Read the clinician fact sheet
- Consent and provide patient with consumer fact sheet
- Complete EVUSHELD Patient Consent and Referral
- Complete Request to Access Evusheld form (Health Services) NOT the GPs and specialists form
- Email both forms to covidtherapy@phcn.vic.gov.au
Once a referral is received via the covidtherapy@phcn.vic.gov.au address contact will be made directly with the client / patient and an appointment organised.
EVUSHELD can also be obtained with a GP prescription and administered by a participating Supercare Pharmacy